Replies to post #9364 on Synaptogenix Inc (SNPX)

[runncoach]

Thx trenches

[XenaLives]

Speaking of multi modal:


Anavex 2-73, Normalization of hypertension - peer reviewed in January 2018
https://www.anavex.com/anavex-life-sciences-reports-potential-normalization-of-hypertension-with-anavex2-73-published-in-the-journal-of-clinical-hypertension/

[InTheTrenches]

NTRP is the leader in potential Alzheimer's treatments, hands-down. NTRP has the most advanced positive results in clinical trials.

AVXL? It is of no concern to NTRP and meaningless:

- AVXL has good preclinical results? Who cares...prove it in a real trial.

- AVXL reported results from an open-label phase 2 trial? Now do a real double-blind placebo-controlled trial; readout of that trial in 2 years?
Who cares for the next few years.

- AVXL has a cost-effective drug? Could be worthless, until it can prove something in trials. Who cares if it's cost-effective, until it proves something in clinical trials.